微质介导的内皮保护:SHPL-49在缺血性中风中的作用
Yu Zhao1, Pei Zhang1, Jiange Zhang1
1The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|October 10, 2024
概括
沙利德化物衍生物SHPL-49通过调节微质细胞,保护大脑内皮细胞免受缺血性中风的侵害. 这种化合物减少神经炎症并改善血管功能,为中风治疗提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 修改后的沙利德化物SHPL-49在脑缺血模型中显示出神经保护作用.
- SHPL-49增强了巨细胞中的血管内皮生长因子-a (VEGF-a) mRNA.
- 微质细胞,大脑巨细胞,是大脑缺血反应和质血管单元相互作用的关键.
研究的目的:
- 调查SHPL-49的神经保护作用是否通过微质依赖于大脑缺血后内皮功能障碍的改善来调解.
- 阐明SHPL-49对微质和内皮细胞的作用背后的分子机制.
主要方法:
- 使用了一种老鼠永久中脑动脉封闭 (pMCAO) 模型.
- 评估了微质依赖性内皮功能障碍,VEGF表达和MMP-9释放.
- 在微质贫乏的pMCAO大鼠中进行了MRI分析.
- 在微质介导的大脑内皮细胞功能上进行了体外实验.
- 研究的信号通路包括VEGFR2/Akt/eNOS和p38 MAPK/MMP-9.
主要成果:
- 在pMCAO模型中,SHPL-49减轻了微质依赖的内皮功能障碍.
- SHPL-49提高了VEGF的调节,并抑制了微质细胞中MMP-9的释放.
- 核磁共振扫描证实,SHPL-49的保护作用取决于微质细胞的存在.
- 实验室研究证实了微质介导的大脑内皮细胞的保护.
- 在内皮细胞中,SHPL-49激活了VEGFR2/Akt/eNOS,并在微质中抑制了p38 MAPK/MMP-9.
结论:
- SHPL-49通过依赖微质的机制改善脑缺血引起的内皮功能障碍.
- SHPL-49的作用包括激活内皮VEGFR2/Akt/eNOS和抑制微质p38 MAPK/MMP-9.
- 这些发现支持SHPL-49用于治疗缺血性中风的临床评估.
更多相关视频
12:42Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
Published on: December 28, 2014
15.6K
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
1.8K
相关概念视频
Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
